apheresis
Showing 1 - 25 of 1,019
Vascular Access Complications for Therapeutic Apheresis in
Recruiting
- Vascular Access Complication
- Apheresis Related Complication
-
Nancy, FranceCentral Hospital
May 30, 2023
Citrate Effects and Bone Density in Long-Term Apheresis Donors
Completed
- Healthy Apheresis Donors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 22, 2022
Healthy Subjects Trial in El Segundo (N-803)
Not yet recruiting
- Healthy Subjects
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Sep 14, 2023
Hypercholesterolemia, Familial, Dyslipidemias, Cardiovascular Diseases Trial in Rostock, Dresden (Lipoprotein Apheresis MONET
Completed
- Hypercholesterolemia, Familial
- +2 more
- Lipoprotein Apheresis MONET and DALI
- Lipoprotein Apheresis DIAMED and DALI
-
Rostock, Mecklenburg-Vorpommern, Germany
- +1 more
Jul 27, 2022
Fatigue, Post-Acute COVID-19 Syndrome Trial in Hannover (Immunoadsorption vs. sham immunoadsorption)
Not yet recruiting
- Fatigue
- Post-Acute COVID-19 Syndrome
- Immunoadsorption vs. sham immunoadsorption
-
Hannover, Lower Saxony, GermanyHannover Medical School
Jul 24, 2023
LDL-Apheresis for FSGS CardioRenal Outcomes
Enrolling by invitation
- Focal Segmental Glomerulosclerosis
- No intervention
-
Cincinnati, Ohio
- +1 more
Jan 25, 2023
Tolerance of Therapeutic Apheresis in Paediatric
Completed
- Apheresis Related Complication
- Efficacy of apheresis
-
Montpellier, FranceUh Montpellier
Apr 11, 2022
Stroke, Ischemic Trial in Ulm (CRP apheresis)
Recruiting
- Stroke, Ischemic
- CRP apheresis
-
Ulm, Bayern, GermanyAbteilung für Neurologie, Universität Ulm
Mar 8, 2022
ST Elevation Myocardial Infarction, C-Reactive Protein, Apheresis Trial in Austria, Germany (Selective CRP apheresis using the
Recruiting
- ST Elevation Myocardial Infarction
- +3 more
- Selective CRP apheresis using the PentraSorb®-CRP system
-
Graz, Austria
- +4 more
Jul 11, 2022
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Fluid Loss Trial in Denver (CM-1500)
Recruiting
- Fluid Loss
- CM-1500
-
Denver, ColoradoVitalant Blood Donation
Jun 3, 2022
Two is Better Than One: A Novel Venous Access System for
Recruiting
- Apheresis
- PowerPort
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Apr 26, 2022
Stroke, Ischemic Trial in Berlin (CRP apheresis)
Recruiting
- Stroke, Ischemic
- CRP apheresis
-
Berlin, GermanyZentrum für Schlaganfallforschung (CSB) / Klinik für Neurologie
Mar 24, 2022
Apheresis of Patients With Immunodeficiency
Recruiting
- LAD-1
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)
Terminated
- Decreased Immunologic Activity
- Antibody-mediated Rejection
- Combined apheresis
-
Vienna, AustriaDivision of Medicine III, Dpt. of Nephrology and Dialysis, Medic
Aug 22, 2022
Bone Density Trial in Milwaukee (high frequency voluntary apheresis blood donation)
Completed
- Bone Density
- high frequency voluntary apheresis blood donation
-
Milwaukee, WisconsinBloodCenter of Wisconsin
Mar 8, 2022
Hypertriglyceridemia-associated Acute Pancreatitis: Apheresis
Completed
- Acute Pancreatitis
- conservative versus plasmapharesis therapy
-
Kfar Saba, IsraelMeir Medical Center
Apr 12, 2022
Plasma Exchange Trial in Dallas (20-gauge BD Nexiva Diffusics)
Completed
- Plasma Exchange
- 20-gauge BD Nexiva Diffusics
-
Dallas, TexasZale Lipshy Pavilion
May 11, 2022
Covid19 Trial in Germany (CRP-apheresis)
Recruiting
- Covid19
- CRP-apheresis
-
Essen, NRW, Germany
- +3 more
Mar 29, 2022
Hyperlipoproteinemia(a) Trial (Pelacarsen (TQJ230) 80 mg s.c., Corresponding Placebo)
Not yet recruiting
- Hyperlipoproteinemia(a)
- Pelacarsen (TQJ230) 80 mg s.c.
- Corresponding Placebo
- (no location specified)
Mar 22, 2022
Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)
Recruiting
- Allogeneic Granulocyte Donation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Healthy Trial (BioCaptis)
Not yet recruiting
- Healthy
- BioCaptis
- (no location specified)
Apr 12, 2023
Lipoproteinemia, Apheresis Related Complication, Cardiovascular Diseases Trial in Dresden (Dextran sulfate absorption
Recruiting
- Lipoproteinemia
- +2 more
- Dextran sulfate absorption (LIPOSORBER® D - Kaneka Pharma Europe NV)
- +3 more
-
Dresden, GermanyCarl Gustav Carus University Hospital Dresden, Technische Univer
Dec 20, 2021
Blood Components From Healthy Donors for In Vitro Research Use
Recruiting
- Blood Donors
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Hemorrhage, Platelets; Defect, Bleeding Trial in Seattle (Cold stored platelets in 100% plasma stored for 10-14 days, Room
Not yet recruiting
- Hemorrhage
- +3 more
- Cold stored platelets in 100% plasma stored for 10-14 days
- Room temperature stored platelets in 100% plasma stored for up to 7 days
-
Seattle, WashingtonSwedish Medical Center - Cherry Hill
Jan 21, 2022